- I'm sure you've seen this report:
- "Chinese doctors suggest AIDS patients may be resistant
- Chinese researchers are studying why none of several
dozen AIDS patients who shared a hospital ward with people suffering from
Severe Acute Respiratory Syndrome, or SARS, acquired the disease despite
the fact that some health care workers on the ward did contract SARS, Newsday
reports. The patients shared a hospital floor in the city of Gaungzhou,
where the SARS outbreak seemed to have peaked in February. "I am wondering
why there was no SARS virus coinfection in the AIDS cases," said Zhang
Fujie, China's director of AIDS treatment and care. "We are exchanging
information with Hong Kong on this. We will continue to try to understand
- Some AIDS experts in the country are speculating that
the antiretroviral drugs given to the AIDS patients might have somehow
blocked SARS infection. David Ho, of the New York City-based Aaron Diamond
AIDS Research Laboratory, and Yuen Kowk-yung, of the University of Hong
Kong, are now exploring the use of anti-HIV drugs to treat SARS.
- Another theory being examined is that SARS doesn't actually
cause death but that a strong immune response to the SARS virus precipitates
the destruction of cells in the lungs and other parts of the body that
brings on the pneumonia-like complications. Because AIDS patients have
impaired immune systems, their immune responses to the SARS virus are less
vigorous and less likely to lead to this complication. That theory is backed
by limited evidence showing that treatment with steroids, which diminish
immune system responses, has some effectiveness in combating SARS."
- Take a look at these two articles posted on your site,
- Thanks to you, this information has made it out and people
are listening. You had this information posted on your website for approximately
14 days prior to the above story. My article "Further thoughts on
SARS treatment" gives the exact specifics of the immunology likely
to be going on in SARS. It is tumor necrosis factor alpha (TNF-a) that
is destroying surfactin on lung surfaces that causes the disease to progress
and it is a hyperimmune response that is driving TNF-a production.
- Let's hope they give us both credit for being on the
- I have also attached a .PDF file which shows the escalating
mortality rate of SARS. In 6 months, at the current escalation, SARS mortality
rate will be approximately 18%... about 1 in 5 persons infected will die.
Let's hope the treatments that I have suggested in the articles posted
on your website significantly decrease the mortality rates that could appear
in some months.
- Bob Lee